Literature DB >> 6970643

Naturally occurring human antibodies to the F(ab')2 portion of IgG.

H Nasu, D S Chia, D W Knutson, E V Barnett.   

Abstract

Antibodies to the F(ab')2 portion of IgG were detected in the sera of patients and normals using a heat-aggregated F(ab')2 fragment in a liquid-phase radioimmunoassay. The antibodies were found in 72% of 82 rheumatoid arthritis patients, in less than 20% of patients with other diseases and in a few normal subjects. Anti-F(ab')2 antibodies were distinct from previously described anti-Fc antibodies and 'serum agglutinators'. They reacted with intact IgG, F(ab')2 and IgM in binding and inhibition assays and they appeared to have specificity for the Fd portion of IgG molecules, possibly to the VH region. The anti-F(ab')2 antibodies were of both 7S IgG and 19S IgM classes and were found in sera as components of intermediate size (between 7S and 19S) and large size (greater than 19S) immune complexes. The possible contribution of autologous anti-F(ab')2 to abnormal immunoregulation is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970643      PMCID: PMC1537106     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  GM(F)--A DETERMINANT OF HUMAN GAMMA-GLOBULIN.

Authors:  E R GOLD; C ROPARTZ; L RIVAT; P Y ROUSSEAR
Journal:  Vox Sang       Date:  1965 May-Jun       Impact factor: 2.144

2.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

3.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

4.  Characterization and measurement of anti-IgG antibodies in human sera by radioimmunoassay (RIA).

Authors:  J Yamagata; E V Barnett; D W Knutson; H Nasu; D Chia
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

6.  Complementary idiotypy in the regulation of the immune response.

Authors:  H Köhler; D A Rowley; T DuClos; B Richardson
Journal:  Fed Proc       Date:  1977-02

7.  Hypervariable regions, idiotypy, and the antibody-combining site.

Authors:  J D Capra; J M Kehoe
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

8.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

9.  Specific suppression of the antibody response by antibodies to receptors.

Authors:  H Cosenza; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

10.  Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody.

Authors:  H Cosenza; H Köhler
Journal:  Science       Date:  1972-06-02       Impact factor: 47.728

View more
  29 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.

Authors:  T Wada; I Ezaki; M Shingu; S Nonaka; E Ohtsuka; M Yasuda; M Nobunaga
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

3.  Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.

Authors:  Z J Pan; C J Anderson; H A Stafford
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

4.  Relationship between naturally occurring human antibodies to casein and autologous antiidiotypic antibodies: implications for the network theory.

Authors:  C Cunningham-Rundles; Z K Feng; Z Zhou; K R Woods
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

Review 5.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

6.  Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome.

Authors:  J R Yu; E T Lennette; S Karpatkin
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.

Authors:  F P Schena; A Pastore; N Ludovico; R A Sinico; S Benuzzi; V Montinaro
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

8.  Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed.

Authors:  J E Persselin; R H Stevens
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

9.  Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class.

Authors:  A D Burt; R S Anthony; W S Hislop; I A Bouchier; R N MacSween
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

10.  Differences in anti-Fab antibodies in adult and late onset rheumatoid arthritis.

Authors:  F Gamerith; G J Zlabinger; O Scherak; G Kolarz; M Schemper; H Heinzl; J E Menzel
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.